Pulmonary Inflammatory Rhabdomyoblastic Tumor: Case Report
DOI:
https://doi.org/10.32635/2176-9745.RBC.2023v69n1.3363Keywords:
lung neoplasms, sarcoma, leiomyosarcoma, rhabdomyosarcomaAbstract
Introduction: Primary lung sarcomas are rare malignant tumors with an estimated incidence of around 0.5% of all lung neoplasms. Of their typifications described in the literature, two especially, leiomyosarcomas and rhabdomyosarcomas, have similarities in their genetic, morphological and immunohistochemical profile, which led them to be classified with the same name: inflammatory rhabdomyoblastic tumor. This type of tumor usually affects soft tissues in the extremities and trunk, and predominates among young and middle-aged men. Due to the small number of cases of rhabdomyoblastic tumors reported in the literature, both their diagnosis and treatment are poorly described. Case report: Female patient, 19 years old, who had three episodes of respiratory infection in the lower lobe of the right lung in a period of 18 months. Computed tomography of the chest showed obstruction of the intermediate bronchus and areas of bronchiectasis in the right lower lobe. In view of this, a lower middle bilobectomy was performed through robotic surgery. The patient was discharged from hospital three days after the operation. Immunohistochemistry revealed low-grade inflammatory rhabdomyoblastic tumor. Conclusion: This report described a case of a rare lung tumor, submitted to a surgical technique not yet reported for this type of pathology.
Downloads
References
Qin BD, Jiao XD, Zang YS. Primary pulmonary leiomyosarcoma: a population-based study. Lung Cancer. 2018;116:67-72. doi: https://doi.org/10.1016/j.lungcan.2017.12.015 DOI: https://doi.org/10.1016/j.lungcan.2017.12.015
Gladish GW, Sabloff BM, Munden RF, et al. Primary thoracic sarcomas. Radiographics. 2002;22(3):621-37. doi: https://doi.org/10.1148/radiographics.22.3.g02ma17621 DOI: https://doi.org/10.1148/radiographics.22.3.g02ma17621
Etienne-Mastroianni B, Falchero L, Chalabreysse L, et al. Primary sarcomas of the lung: a clinicopathologic study of 12 cases. Lung Cancer. 2002;38(3):283-9. doi: https://doi.org/10.1016/s0169-5002(02)00303-3 DOI: https://doi.org/10.1016/S0169-5002(02)00303-3
Enzinger FM, Weiss SW, Meeroff NG. Tumores de tejidos blandos. Buenos Ayres: Médica Panamericana; 1985.
Hajdu SI. Differential diagnosis of soft tissue and bone tumors. Philadelphia: Lea & Febiger; 1986.
Lee JC, Li WS, Kao YC, et al. Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors. Mod Pathol. 2021 Jul;34(7):1434-8. doi: https://doi.org/10.1038/s41379-021-00797-8 DOI: https://doi.org/10.1038/s41379-021-00797-8
Folpe AL. Response to Lee et al: Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors. Mod Pathol. 2021;34(7):1439. doi: https://doi.org/10.1038/s41379-021-00819-5 DOI: https://doi.org/10.1038/s41379-021-00819-5
Cloutier JM, Charville GW, Mertens F, et al. "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor". Mod Pathol. 2021;34(4):758-69. doi: https://doi.org/10.1038/s41379-020-00703-8 DOI: https://doi.org/10.1038/s41379-020-00703-8
Conselho Nacional de Saúde (BR). Resolução nº 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção 1:59.
Michal M, Rubin BP, Kazakov DV, et al. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor. Virchows Arch. 2020;477(2):219-30. doi: https://doi.org/10.1007/s00428-020-02774-z DOI: https://doi.org/10.1007/s00428-020-02774-z
Geiersbach K, Kleven DT, Blankenship HT, et al. Inflammatory rhabdomyoblastic tumor with progression to high-grade rhabdomyosarcoma. Mod Pathol. 2021;34(5):1035-6. doi: https://doi.org/10.1038/s41379-021-00791-0 DOI: https://doi.org/10.1038/s41379-021-00791-0
Bourgeau M, Martinez AP. Histiocyte-rich rhabdomyoblastic tumor: a report of two cases and a review of the differential diagnoses. Virchows Arch. 2021;478(2):367-73. doi: https://doi.org/10.1007/s00428-020-02857-x. Erratum in: Virchows Arch. 2020;477(5):763. doi: https://doi.org/10.1007/s00428-020-02873-x DOI: https://doi.org/10.1007/s00428-020-02857-x
Kindblom LG, Angervall L. Nasal polyps with atypical stroma cells: a pseudosarcomatous lesion. A light and electron-microscopic and immunohistochemical investigation with implications on the type and nature of the mesenchymal cells. Acta Pathol Microbiol Immunol Scand A. 1984;92(1):65-72. DOI: https://doi.org/10.1111/j.1699-0463.1984.tb04378.x
Kerr DA, Thompson LDR, Tafe LJ, et al. Clinicopathologic and genomic characterization of inflammatory myofibroblastic tumors of the head and neck: highlighting a novel fusion and potential diagnostic pitfall. Am J Surg Pathol. 2021;45(12):1707-19. doi: https://doi.org/10.1097/PAS.0000000000001735 DOI: https://doi.org/10.1097/PAS.0000000000001735
Janssen JP, Mulder JJ, Wagenaar SS, et al. Primary sarcoma of the lung: a clinical study with long-term follow-up. Ann Thorac Surg. 1994;58(4):1151-5. doi: https://doi.org/10.1016/0003-4975(94)90476-6 DOI: https://doi.org/10.1016/0003-4975(94)90476-6
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
